RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEA62FEC5B159F50CEC
https://w3id.org/ripe/ripe-kg/publication-details/RIPEA62FEC5B159F50CEC
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA62FEC5B159F50CEC |
prov:used |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prism:endingPage |
256 |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prism:issn |
0302-2838 |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prism:publicationDate |
2013-04-10 |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prism:publicationName |
European Urology |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prism:startingPage |
249 |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
dcterms:publisher |
ripekg:publisher/RIPEP4BE129AB189EEF46Elsevier BV |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
dcterms:title |
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA62FEC5B159F50CEC |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA62FEC5B159F50CEC |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1016%2Fj.eururo.2013.04.001OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEA62FEC5B159F50CECOnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA62FEC5B159F50CEC-inspectai-1-1 |